Histamine H1- and H2-receptors participate to provide metabolic energy differently.


Journal

Fundamental & clinical pharmacology
ISSN: 1472-8206
Titre abrégé: Fundam Clin Pharmacol
Pays: England
ID NLM: 8710411

Informations de publication

Date de publication:
Dec 2022
Historique:
revised: 21 06 2022
received: 09 04 2022
accepted: 06 07 2022
pubmed: 9 7 2022
medline: 15 11 2022
entrez: 8 7 2022
Statut: ppublish

Résumé

Histamine participates in a variety of physiological functions. The local effects of histamine have a role to provide metabolic energy for the tissues. The objective of this work is to study the mechanism whereby histamine affects serum glucose and liver glycogen fractions. Six groups of 10 male rats received two injections with histamine, H1-agonist (dipyridylethylamine), H2-agonist (dimaprit), H1-agonist plus H1-antagonist (cetirizine), or H2-agonist plus H2-antagonist (famotidine). Serum glucose and liver glycogen fractions were measured. Histamine caused a significant increase in serum glucose (163.7 ± 5.4 vs. 153.2 ± 3.3 mg/dl, p = 0.023). The effect of histamine was mimicked by selective H1-agonist (164.2 ± 3.5 vs. 152.8 ± 2.9 mg/dl, p = 0.005) but not with H2-agonist (159.3 ± 3.7 vs. 156.3 ± 4.8 mg/dl, p = 0.281). The effect of H1-agonist was abolished in the presence of selective H1-antagonist. Treatment by H1- but not H2-agonist decreased total glycogen by about 35% (30.6 ± 0.5 vs. 47.3 ± 2.8 mg/g wet weight of liver, p = 0.003). The decrease happened wholly in ASG fraction (26.8 ± 1.2 vs. 43.7 ± 3.2 mg/g wet weight of liver, p = 0.004), while AIG did not change significantly (4.2 ± 0.5 vs. 4.5 ± 0.4 mg/g wet weight of liver, p = 0.724). Histamine causes to decrease glycogen in the liver and increased serum glucose. The effects of histamine were mediated via H1-receptors. ASG was metabolically active fraction of liver glycogen in this process. The results confirm the role of histamine in providing metabolic energy of the tissues.

Identifiants

pubmed: 35802355
doi: 10.1111/fcp.12814
doi:

Substances chimiques

Receptors, Histamine H2 0
Histamine 820484N8I3
Liver Glycogen 0
Receptors, Histamine H1 0
Histamine H2 Antagonists 0
Glycogen 9005-79-2
Glucose IY9XDZ35W2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1031-1037

Informations de copyright

© 2022 Société Française de Pharmacologie et de Thérapeutique. Published by John Wiley & Sons Ltd.

Références

Rosengard BR, Mahalik C, Cochrane DE. Mast cell secretion: differences between immunologic and non-immunologic stimulation. Agents Actions. 1986;19(3-4):133-140. doi:10.1007/BF01966197
Hass HL, Panula P. Histamine receptors. Neuropharmacology. 2016;106:1-2. doi:10.1016/j.neuropharm.2016.04.007
Tabarean IV. Histamine receptor signaling in energy homeostasis. Neuropharmacology. 2016;106:13-19. doi:10.1016/j.neuropharm.2015.04.011
Luttrell MJ, Halliwill JR. The intriguing role of histamine in exercise responses. Exerc Sport Sci Rev. 2017;45(1):16-23. doi:10.1249/JES.0000000000000093
Peterson C. Role of energy metabolism in histamine release. A study on isolated rat mast cells. Acta Physiol Scand Suppl. 1974;413:1-34.
Medrano S, Gruenstein E, Dimlich RV. Histamine stimulates glycogenolysis in human astrocytoma cells by increasing intracellular free calcium. Brain Res. 1992;592(1-2):202-207. doi:10.1016/0006-8993(92)91677-7
Arbonés L, Picatoste F, García A. Histamine stimulates glycogen breakdown and increases Ca2+ permeability in rat astrocytes in primary culture. Mol Pharmacol. 1990;37(6):921-927.
Mine T, Kojima I, Ogata E. Mechanism of glycogenolytic action of histamine in rat hepatocytes. Am J Physiol. 1991;261(6):G1000-G1004. doi:10.1152/ajpgi.1991.261.6.G1000
García-Sáinz JA, de la Garza MC, Contreras-Rodríguez JL, Nájera-Alvarado A. Effects of histamine on the metabolism of isolated rat hepatocytes: roles of H1- and H2-histamine receptors. Mol Pharmacol. 1987;31(3):253-258.
Stasiewicz J, Namiot Z, Szalaj W, Sobolewski K, Górski J. Triacylglycerol and glycogen contents in the human gastric mucosa: effect of histamine H2, muscarinic and gastrin receptors blockade. Acta Med Hung. 1989;46(2-3):189-195.
Cecil HC, Bitman J, Wrenn TR. Effect of histamine and estrogen on the glycogen content of the rat uterus. Endocrinology. 1964;74:701-708. doi:10.1210/endo-74-5-701
Nikfar A, Rasouli M. Hypolipemic effects of histamine is due to inhibition of VLDL secretion from the liver: involvement of both H1 and H2-receptors. Arch Biochem Physiol. 2020:1-5. doi:10.1080/13813455.2020.1782436
Rasouli M, Shokri-Afra H, Ostovar-Ravari A. A new protocol for separation of acid soluble and insoluble fractions from total glycogen and simultaneous measurements. Eur Rev Med Pharmacol Sci. 2015;19(10):1785-1789.
Shokri-Afra H, Ostovar-Ravari A, Rasouli M. Improvement of the classical assay method for liver glycogen fractions: ASG is the main and metabolic active fraction. Eur Rev Med Pharmacol Sci. 2016;20(20):4328-4336.
Rasouli M, Mohammadi-Pilehdarboni H. Pitfalls in extraction, separation and measurement of glycogen fractions: modification of the new protocol. Trends Carbohydr Res. 2021;12:21-28.
Rasouli M, Ostovar-Ravari A, Shokri-Afra H. Characterization and improvement of phenol-sulfuric acid microassay for glucose-based glycogen. Eur Rev Med Pharmacol Sci. 2014;18(14):2020-2024.
Rasouli M, Kiasari AM. Interactions of lipoprotein(a) with diabetes mellitus, apolipoprotein B and cholesterol enhance the prognostic values for coronary artery disease. Clin Chem Lab Med. 2008;46(5):667-673. doi:10.1515/CCLM.2008.137
Emhoff CW, Barrett-O'Keefe Z, Padgett RC, Hawn JA, Halliwill JR. Histamine-receptor blockade reduces blood flow but not muscle glucose uptake during postexercise recovery in humans. Exp Physiol. 2011;96(7):664-673. doi:10.1113/expphysiol.2010.056150
Pellinger TK, Simmons GH, Maclean DA, Halliwil JR. Local histamine H1- and H2-receptor blockade reduces postexercise skeletal muscle interstitial glucose concentrations in humans. Appl Physiol Nutr Metab. 2010;35(5):617-626. doi:10.1139/H10-055
Niijima-Yaoita F, Tsuchiya M, Ohtsu H, et al. Roles of histamine in exercise-induced fatigue: favoring endurance and protecting against exhaustion. Biol Pharm Bull. 2012;35(1):91-97. doi:10.1248/bpb.35.91
Van der Stede T, Blancquaert L, Stassen F, et al. Histamine H1 and H2 receptors are essential transducers of the integrative exercise training response in humans. Sci Adv. 2021;7(16):eabf2856. doi:10.1126/sciadv.abf2856
Jorgensen EA, Knigge U, Warberg J, Kjaer A. Histamine and regulation of body weight. Neuroendocrinology. 2007;86(3):210-214. doi:10.1159/000108341
Provensi G, Blandina P, Passan MP. The histaminergic system as a target for the prevention of obesity and metabolic syndrome. Neuropharmacology. 2016;106:3-12. doi:10.1016/j.neuropharm.2015.07.002
Koyama Y, Imoto M, Tanaka M, et al. Effect of histamine H1-receptor antagonist on the regulation of carbohydrate and lipid metabolism in rat liver. Biochem Int. 1989;18(2):399-403.
Mika K, Szafarz M, Bednarski M, et al. Metabolic benefits of novel histamine H3 receptor ligands in the model of excessive eating: the importance of intrinsic activity and pharmacokinetic properties. Biomed Pharmacother. 2021;142:111952. doi:10.1016/j.biopha.2021.111952
Rasouli M, Trischuk T, Lehner R. Calmodulin antagonist W-7 inhibits de novo synthesis of cholesterol and suppresses secretion of de novo synthesized and preformed lipids from cultured hepatocytes. Biochem Biophys Acta. 2004;1682(1-3):92-101. doi:10.1016/j.bbalip.2004.02.002
Imoto M, Tsuchie K, Tanaka M, Sugiyama S, Ozawa T. Predominance of histamine H1 receptors on liver plasma membrane. Biochem Biophys Res Commun. 1985;127(3):885-889. doi:10.1016/S0006-291X(85)80026-7
Akiyama Y, Mukai T, Kamei C, Tasaka K. Histamine lipolysis I: changes in the free fatty acid levels of dog plasma after intravenous infusion of histamine. Methods Find Exp Clin Pharmacol. 1990;12(5):315-324.
Rasouli M, Nesarhosseini V, Kiasari AM, et al. The multiplicative interactions of leukocyte counts with some other risk factors enhance the prognostic value for coronary artery disease. Cardiol J. 2011;18(3):246-253.

Auteurs

Hanieh Mohammadi-Pilehdarboni (H)

Immunogenetic Research Center, Department of Clinical Biochemistry and Genetics, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran.

Mehdi Rasouli (M)

Immunogenetic Research Center, Department of Clinical Biochemistry and Genetics, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH